{
    "clinical_study": {
        "@rank": "1759", 
        "brief_summary": {
            "textblock": "This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over\n      study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and\n      obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes."
        }, 
        "brief_title": "Evaluation of the Effect of Pramlintide on Satiety and Food Intake", 
        "condition": [
            "Diabetes Mellitus, Type 1", 
            "Diabetes Mellitus, Type 2"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "For Healthy Volunteers:\n\n          -  BMI >=20 to <=25kg/m2 or >=30 to <=40 kg/m2\n\n        For Subjects with Type 1 or Type 2 Diabetes:\n\n          -  Treated with insulin for at least 6 months prior to screening\n\n          -  HbA1c value between 6.5-10% inclusive\n\n          -  BMI between 20-40kg/m2"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "August 1, 2002", 
        "id_info": {
            "nct_id": "NCT00042601", 
            "org_study_id": "137-149"
        }, 
        "intervention": {
            "intervention_name": "Pramlintide acetate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Pramlintide", 
                "Islet Amyloid Polypeptide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "lastchanged_date": "June 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Adelaide", 
                    "country": "Australia", 
                    "state": "South Australia", 
                    "zip": "5000"
                }, 
                "name": "Royal Adelaide Hospital"
            }
        }, 
        "location_countries": {
            "country": "Australia"
        }, 
        "official_title": "A Single Center, Randomized, Double-blind, Placebo-controlled, Two-period, Crossover Study Evaluating the Acute Effect of Pramlintide on Satiety and Food Intake in Normal-weight and Obese Non-diabetic Subjects and in Insulin Treated Subjects With Type 1 and Type 2 Diabetes Mellitus", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2003", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00042601"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2002", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }, 
    "geocoordinates": {
        "Royal Adelaide Hospital": "-34.929 138.6"
    }
}